H Hasan New member 6 Tem 2022 #1 Eisai says Alzheimer’s drug will get priority review in US The Food and Drug Administration accepted the application under the accelerated approval pathway
Eisai says Alzheimer’s drug will get priority review in US The Food and Drug Administration accepted the application under the accelerated approval pathway
